-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 14 Mar 2024 07:00 CET |
HYLORIS | Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives | 20103010 Biotechnology | Income |
| 14 Mar 2024 06:59 CET |
HYLORIS | Communication at the request of the FSMA on the transactions with Qliniq | 20103010 Biotechnology | Other financial transaction |
| 14 Mar 2024 06:59 CET |
HYLORIS | Communiqué à la requête de la FSMA sur les transactions avec QliniQ | 20103010 Biotechnology | Other financial transaction |
| 13 Mar 2024 19:00 CET |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
| 13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
| 13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
| 13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
| 13 Mar 2024 18:30 CET |
EVS BROADC.EQUIPM. | PUBLICATION OF A TRANSPARENCY NOTIFICATION | 15101010 Telecommunications Equipment | Corporate life |
| 13 Mar 2024 18:30 CET |
EVS BROADC.EQUIPM. | PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE | 15101010 Telecommunications Equipment | Corporate life |
| 13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc | 30301010 Life Insurance | - |
| 13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc (La version française suivra) | 30301010 Life Insurance | - |
| 13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc (Nederlandse versie volgt later) | 30301010 Life Insurance | - |
| 13 Mar 2024 10:04 CET |
AGFA-GEVAERT | Correction: The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 10:04 CET |
AGFA-GEVAERT | Correction: De Agfa-Gevaert Groep in 2023: EBITDA van de Groep 52% hoger, onder impuls van de groeimotoren - gereglementeerde informatie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 09:18 CET |
SHURGARD | 20240304 Shurgard finalizes its transaction in German | 35101010 Real Estate Holding and Development | Mergers, Acquiqitions, Transferts |
| 13 Mar 2024 08:20 CET |
TITAN CEMENT | Résultats annuels 2023 | 50101030 Cement | Commercial results |
| 13 Mar 2024 08:19 CET |
TITAN CEMENT | Full Year Results 2023 | 50101030 Cement | Commercial results |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | Jeroen Spruyt appointed as President of Agfa’s Radiology Solutions division | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | Jeroen Spruyt benoemd tot President van Agfa’s divisie Radiology Solutions | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | De Agfa-Gevaert Groep in 2023: EBITDA van de Groep 52% hoger, onder impuls van de groeimotoren - gereglementeerde informatie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:00 CET |
SOLVAY | Solvay fourth quarter and full-year 2023 results | 55201000 Chemicals: Diversified | Corporate life |
| 13 Mar 2024 07:00 CET |
SOLVAY | Résultats du quatrième trimestre et de l’année 2023 | 55201000 Chemicals: Diversified | Corporate life |
| 13 Mar 2024 07:00 CET |
SOLVAY | Solvay 2023 vierde kwartaal en jaarresultaten | 55201000 Chemicals: Diversified | Corporate life |
| 12 Mar 2024 18:21 CET |
BARCO | Transparency declaration by Norges Bank: Threshold crossed | 10102030 Computer Hardware | Share history |
| 12 Mar 2024 15:05 CET |
RECTICEL | Recticel kondigt baanbrekende samenwerking aan tussen Trimo en Pininfarina | 50203015 Plastics | Other subject |
| 12 Mar 2024 15:05 CET |
RECTICEL | Recticel announces landmark collaboration between Trimo and Pininfarina | 50203015 Plastics | Other subject |
| 12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 04/03/2024 to 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 04/03/2024 au 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 04/03/2024 tot 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
| 12 Mar 2024 08:00 CET |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
| 12 Mar 2024 08:00 CET |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
| 12 Mar 2024 08:00 CET |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
| 12 Mar 2024 07:00 CET |
BIOSENIC | BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease | 20103010 Biotechnology | Corporate life |
| 12 Mar 2024 07:00 CET |
BIOSENIC | BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3 | 20103010 Biotechnology | Corporate life |
| 12 Mar 2024 07:00 CET |
SYENSQO | Syensqo full-year 2023 results | 55101000 Diversified Materials | Corporate life |
| 12 Mar 2024 07:00 CET |
SYENSQO | Résultats de l'année 2023 de Syensqo | 55101000 Diversified Materials | Corporate life |
| 12 Mar 2024 07:00 CET |
SYENSQO | Resultaten Syensqo - jaar 2023 | 55101000 Diversified Materials | Corporate life |
| 12 Mar 2024 06:00 CET |
NYRSTAR | Nyrstar NV – Petition for interim measures received on 11 March 2024 | 55102050 Nonferrous Metals | Other subject |
| 12 Mar 2024 06:00 CET |
NYRSTAR | Nyrstar NV – Verzoekschrift voor voorlopige maatregelen ontvangen op 11 maart 2024 | 55102050 Nonferrous Metals | Other subject |
| 11 Mar 2024 18:09 CET |
GBL | GBL - Transacties op GBL-aandelen 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 11 Mar 2024 18:08 CET |
GBL | GBL - Transactions sur actions propres 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 11 Mar 2024 18:07 CET |
GBL | GBL - Transactions on GBL shares 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
| 11 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis Launches Share Buyback Program 2024 under its Long-term Incentive Plan | 55201000 Chemicals: Diversified | Other financial transaction |
| 11 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis kondigt Aandeleninkoopprogramma 2024 aan onder zijn langetermijnstimulusplan | 55201000 Chemicals: Diversified | Other financial transaction |
| 11 Mar 2024 08:35 CET |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 11 Mar 2024 08:35 CET |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
| 11 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System | 20101025 Health Services | - |
| 11 Mar 2024 07:14 CET |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
| 11 Mar 2024 07:13 CET |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |